Vaccine News and Research

Latest Vaccine News and Research

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Researchers demonstrated that a trivalent vaccine against SARS-CoV-2 improved the breadth of humoral immune responses in mice.

19 Dec 2022

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Researchers reported the waning of antibodies against SARS-CoV-2 in the six months following a booster dose of the mRNA COVID-19 vaccine.

19 Dec 2022

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Researchers evaluated the immunogenicity and safety of the COVID-19 bivalent mRNA vaccine mRNA-1273.222 and tested the neutralizing ability of the two bivalent vaccines — mRNA-1273.222 and mRNA-1273.214 — against the newly emergent Omicron subvariants.

19 Dec 2022

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

A new Eurosurveillance study investigated the efficacy of the MVA-BN vaccine, which was administered to individuals after exposure to the virus.

18 Dec 2022

An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shots

A new study in the journal Vaccines aimed to analyze the long-term kinetics of SARS-CoV-2 specific T cell and humoral responses following primary and booster vaccinations in previously infected individuals.

18 Dec 2022

Genome assembly tool could spur the development of new treatments for tuberculosis

Researchers have developed a novel genome assembly tool that could spur the development of new treatments for tuberculosis and other bacterial infections.

16 Dec 2022

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Less known to the general public, mucosal vaccination via the mucus membranes could provide robust protection against SARS-CoV-2 infections.

16 Dec 2022

Trial results confirm the safety of three different Ebola vaccine regimens

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to supplement the available data to develop a safe and effective Ebola vaccine strategies in adults and children alike.

16 Dec 2022

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

In one of the first large, real-world studies comparing the effectiveness of COVID-19 vaccines versus natural immunity in protecting against death, hospitalizations and emergency department (ED) visits for any cause, including COVID, research-scientists from Regenstrief Institute, Indiana University School of Medicine and Vanderbilt University Medical Center report that people of all age groups benefited significantly more from vaccination than natural immunity acquired from a previous COVID infection.

16 Dec 2022

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Researchers developed a one-dose subunit vaccine for the induction of durable, potent, and broad immunity against SARS-CoV-2.

16 Dec 2022

Natural substances show great therapeutic potential to inhibit influenza viruses

Fever, cough, sore throat, and general malaise - the cold season is here, and not only corona but also influenza viruses are spreading again at a rapid pace.

16 Dec 2022

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

Researchers used serological measurements from a longitudinal cohort to evaluate the use of binding antibodies against the SARS-CoV-2 spike protein receptor binding domain as correlates of protection against the immune evasive Omicron subvariants BA.1 and BA.2.

16 Dec 2022

The impact of the US vaccination program on reducing infections, hospitalizations, and deaths

A recent study reported that in the two years following the initiation of the US COVID-19 vaccination campaign, over 18 million hospitalizations and three million deaths have been prevented, and close to $1.15 trillion have been saved in medical costs.

16 Dec 2022

mRNA vaccine methodologies: Production, value and spectrometer use

To be decided by the editor

From Thermo Fisher Scientific – Pharmaceutical and Biopharmaceutical Solutions 16 Dec 2022

Study finds disparities in health care coverage, hampered COVID-19 vaccination efforts in rural areas

Vaccine hesitancy is just one reason fewer people in some parts of the United States have been inoculated against coronavirus.

16 Dec 2022

Guidance on the use of face masks and on outbreaks in care settings has been updated

Guidance on the use of face masks in all care settings and on outbreaks in care homes has been updated to give settings the flexibility to ensure ongoing Covid measures are proportionate.

15 Dec 2022

What is the role of the pediatric gut microbiome in COVID-19?

Recently, scientists have reviewed the available evidence on the gut microbiome in children with COVID-19 and published it in Microorganisms.

15 Dec 2022

Influenza vaccine effectiveness during the 2021–2022 influenza season in the United States

Researchers estimated influenza VE in patients aged ≥6 months seeking outpatient care for ARI due to the influenza A(H3N2) virus between October 2021 and April 2022 in the United States (US).

15 Dec 2022

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Two randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens were safe in both age groups, according to results published today in the New England Journal of Medicine.

15 Dec 2022

Study assesses COVID-19 booster vaccination coverage by demographics and behaviors and experiences toward vaccination among fully vaccinated adults

An early release from the CDC, USA, examines the coverage of booster doses among adults in the USA.

15 Dec 2022

Vaccine News and Research

Latest Vaccine News and Research

Study demonstrates robust antibody response elicited by trivalent protein subunit vaccine against SARS-CoV-2

Rise and waning of SARS-CoV-2 antibody responses induced by mRNA vaccine booster in a healthcare worker population

Safety and immunogenicity of the Omicron BA.4/BA.5-containing bivalent booster mRNA-1273.222

Study examines Mpox prevention with modified vaccinia Ankara (MVA)

An assessment of T cell and antibody immunity against SARS-CoV-2 VOCs and the effect of booster shots

Genome assembly tool could spur the development of new treatments for tuberculosis

Mucosal DNA vaccine provides protection against lethal SARS-CoV-2 in mice

Trial results confirm the safety of three different Ebola vaccine regimens

People of all age groups benefit more from COVID-19 vaccines than natural immunity, real-world study finds

Researchers report the development of robust candidate single immunization PNP hydrogel COVID vaccines

Natural substances show great therapeutic potential to inhibit influenza viruses

Study finds anti-S binding antibody levels are a valid correlate of protection against Omicron BA.1/BA.2 infections

The impact of the US vaccination program on reducing infections, hospitalizations, and deaths

mRNA vaccine methodologies: Production, value and spectrometer use

Study finds disparities in health care coverage, hampered COVID-19 vaccination efforts in rural areas

Guidance on the use of face masks and on outbreaks in care settings has been updated

What is the role of the pediatric gut microbiome in COVID-19?

Influenza vaccine effectiveness during the 2021–2022 influenza season in the United States

Randomized trials demonstrate the safety of Ebola vaccine regimens in adults and children

Study assesses COVID-19 booster vaccination coverage by demographics and behaviors and experiences toward vaccination among fully vaccinated adults

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in